Mol. pharmaceutics 2018 15 2297−2306
WebMolecular Pharmaceutics has been certified as a transformative journal by cOAlition S, committing to a transition to 100% open access in the future. If your research funder has … WebPharmaceutics, an international, peer-reviewed Open Access journal ... PEGylation increased the particle sizes from 256.7 nm (pristine nGO) to 324.6 nm (nGO-PEG), the zeta potential from −32.9 to −21.6 mV, and wrinkled the surface of the ... Passive skin diffusion is possible only for drugs with low molecular weights and intermediate ...
Mol. pharmaceutics 2018 15 2297−2306
Did you know?
Web5 mrt. 2024 · We conclude that small molecule excipients have the potential to improve the physical stability of amorphous APIs. Keywords: amorphous; citric acid; coamorphous; … Web7 mei 2024 · In an earlier investigation, coamorphous systems of ketoconazole (KTZ) prepared with each oxalic (OXA), tartaric (TAR), citric (CIT), and succinic (SUC) acid, …
WebAbstract. A variety of oxazoles can efficiently be prepared, in a single step and in good yield, from primary amides and 1,2-dihaloalkenes using copper-catalysis. This new method allows the regioselective formation of a range of substituted oxazoles. The required 1,2-dihaloalkenes can prepared by simple treatment of alkynes with elemental ... WebPlease note: If you switch to a different device, you may be asked to login again with only your ACS ID.
Web© 2016 American Chemical Society. All Rights Reserved. The following purchase terms apply for articles copyrighted by the American Chemical Society (such articles ... Web7 mei 2024 · Prostate cancer (PCa) is the most prevalent cancer among men in the United States and remains the second-leading cause of cancer mortality in men. Paclitaxel (PTX) is the first line chemotherapy for PCa treatment, but its therapeutic efficacy is greatly restricted by the nonspecific distribution in …
Web20 jan. 2024 · Biopharmaceuticals are at the supreme level of the pharmaceutical market due to their high efficacy, high specificity, and low toxicity profiles [ 1 ]. Recently, nucleic acid (NA) therapeutics have emerged as promising candidates for …
WebMolecular Therapy - Oncolytics, 11, pp. 39-51. 2024. Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3 / CCP3.1 assays. María J. Gómara, Javier Rodríguez, María J. Bleda, J. Pablo Salvador, Raimon Sanmartí and Isabel Haro rotary drones in agricultureWeb5 nov. 2024 · Human serum albumin (HSA) fusion protein is a viable and effective approach to target and inhibit essential intracellular pathways. It has previously been shown that an HSA fusion protein containing a p53-reactivating peptide (rHSA-p53i) retains the binding activity to MDM2 and MDMX, resulting in p5 … stout lake indianaWeb5 feb. 2024 · Insertion of high molecular weight messenger RNA (mRNA) into lyotropic lipid phases as model systems for controlled release formulations for the mRNA was investigated. Low fractions of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) were used as an anchor to load the mRNA into a lamellar lipid matr … stout lake coloradoWebPharmaceutics, Volume 15, Issue 3 (March 2024) – 316 articles Cover Story ( view full-size image ): The delivery of many drugs to the brain is limited by the blood–brain barrier (BBB). Nanoparticle (NP) technologies may be developed to provide targeted drug delivery with controlled release. stout investment bankin philadelphia officeWebMolecular Pharmaceutics. Molecular Pharmaceutics is a peer-reviewed scientific journal covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems, including physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science. stout jamestownWebAB - In an earlier investigation, ketoconazole (KTZ)-organic acid coamorphous systems were prepared, wherein, in the solid-state, there was ionic and/or hydrogen bonding interactions between the drug and the acid (Fung, M.; Berzinš, K.; Suryanarayanan, R. Mol. Pharmaceutics, 2024, 15 (5), 1862-1869). stoutland artWeb5 feb. 2024 · Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. stoutland abilities